ライフサイエンスコーパス: coagulation factor Xa

1 s in the 170, 186, and 220 loops to those of coagulation factor Xa.

2 asured in terms of its inactivation of blood coagulation factor Xa.

3 ontaining the m-cyano group was observed for coagulation factor Xa and for the factor VIIa.tissue fac

4 ne protease inhibitor that directly inhibits coagulation factor Xa and regulates blood coagulation vi

5 Kunitz-type protease inhibitor that inhibits coagulation factor Xa and, in a factor Xa-dependent mann

6 o enhance thrombin generation due to binding coagulation factors Xa and Va and accelerating prothromb

7 rotein C because of direct interactions with coagulation Factors Xa and Va.

8 s as a cofactor-dependent regulator of blood coagulation factors Xa and XIa.

9 otease inhibitor, enhances the inhibition of coagulation factor Xa, and protein Z-dependent protease

10 es of porcine trypsin, human thrombin, human coagulation factor Xa, and the Bacillus subtilis dibasic

11 es of water transferred during inhibition of coagulation factor Xa are compared to water-permeable vo

12 uronate containing pentasaccharide inhibited coagulation factor Xa by 50% relative to the parent comp

13 ) serves as a cofactor for the inhibition of coagulation factor Xa by a plasma protein called PZ-depe

14 or to dramatically enhance the inhibition of coagulation factor Xa by the serpin, protein Z-dependent

15 receptor, hepatocyte growth factor receptor, coagulation factor Xa, contactin 4, kynureninase, neurog

16 o using a conformationally pliant variant of coagulation factor Xa (FXa(I16L)) rendered partially ina

17 ibitor (TFPI) is a potent inhibitor of blood coagulation factor Xa (fXa) and factor VIIa.

18 nstrate synergistic interactions between the coagulation factor Xa (fXa) and the proinflammatory cyto

19 otent tick salivary anticoagulant that binds coagulation factor Xa (FXa) and zymogen FX, with formati

20 or VIIa) pathways in the coagulation system, coagulation factor Xa (FXa) has been a theoretically int

21 Inhibitors of coagulation factor Xa (fXa) have emerged as a new class

22 Direct inhibitors of coagulation factor Xa (FXa) or thrombin are promising or

23 ly inhibited the catalytic activity of blood coagulation factor Xa (fXa), while a third form (AcAPc2)

24 ternative C3 convertase (C3bBb) and inhibits coagulation factor Xa (fXa).

25 s as a cofactor-dependent regulator of blood coagulation factors Xa (FXa) and XIa.

26 The major anticoagulant inhibitor of coagulation factor Xa has been identified from the hookw

27 c activation of the protease domain of human coagulation factor Xa into a bacterial trypsin.

28 Coagulation factor Xa is a plasma serine protease that c

29 ries of novel nonpeptide inhibitors of blood coagulation Factor Xa is described.

30 in Z (PZ), to regulate the function of blood coagulation factor Xa on membrane surfaces.

31 human trypsin and plasmin but not thrombin, coagulation factor Xa, or urokinase-type plasminogen act

32 Cell signaling by coagulation factor Xa (Xa) contributes to pro-inflammato